Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

28 Mar 2025 10:00

RNS Number : 6891C
Computacenter PLC
28 March 2025
 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

(the 'Company')

 

The following notifications are made under Article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Directors of the Company, Persons Discharging Managerial Responsibilities ('PDMR') of the Company and Persons Closely Associated ('PCA') with the Directors and PDMRs.

 

Vesting of Award, Exercise of Option and Subsequent Sale of Shares

 

Computacenter 2017 Deferred Bonus Plan

The Company announces that on 26 March 2025, the following conditional award over Ordinary Shares vested for the Director below. This followed, in accordance with the rules of the Computacenter 2017 Deferred Bonus Plan, the Company vesting tranches of the related conditional 2023 Bonus Award, which was granted on 26 March 2024, over Ordinary Shares. Vesting of this tranche of the 2023 Bonus Award was subject to the completion of a one-year holding period. Further, certain of the Ordinary Shares, resulting from the vesting of the award, were automatically sold for 2554 pence each to cover tax and national insurance liabilities arising in connection with the vesting.

 

DIRECTOR

Number of shares acquired following vesting1

Number of shares automatically sold

Number of shares retained

Mr M J Norris (Director)

7,456

3,515

3,941

1 On 26 March 2025, the Director listed above became entitled to ordinary shares of 75/9 pence each in the capital of the Company, as a result of an Award vesting under the DBP. Awards granted under the DBP Plan vest in two tranches with one-half of the deferred shares from the Bonus Awards vesting after one year and the remaining deferred shares from the Bonus Awards vesting after two years. The shares vesting above relate to the first tranche of the 2023 Bonus Award made on 26 March 2024. The shares were released to the Director on 26 March 2025 when the transaction noted above took place. The vesting amount included 189 shares, awarded as dividend equivalent shares equal in value to dividends that would have been paid on the shares in respect of which the award vests in respect of dividend record dates during the period between the grant date and the vesting date.

 

The relevant FCA notifications are set out below.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Details of Director/Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Michael John Norris

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Executive Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired following the vesting of a conditional award, made on 26 March 2024, under the Computacenter 2017 Deferred Bonus Plan (the '2023 Bonus Award'). There is no price payable on the grant or exercise of the 2023 Bonus Award. Vesting of this tranche of the 2023 Bonus Award was subject to the completion of a one year holding period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

7,267

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

7,267

 

4(e)

 

 

Date of the transaction

 

 

26-03-2025

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired as dividend equivalents related to the grant and vesting of a conditional award, made on 26 March 2024, under the Computacenter 2017 Deferred Bonus Plan (the '2023 Bonus Award Dividend Equivalents'). There is no price payable on the acquisition of the Bonus Award Dividend Equivalents.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

189

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

189

 

4(e)

 

 

Date of the transaction

 

 

26-03-2025

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Sale of Ordinary Shares. Automatic sale of 3,515 Shares acquired under the Computacenter 2017 Deferred Bonus Plan to cover tax and national insurance liabilities arising in connection with the vesting.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

25.54

 

3,515

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

25.54

 

 

 

3,515

 

4(e)

 

 

Date of the transaction

 

 

26-03-2025

 

 

4(f)

 

 

Place of the transaction

 

 

XLON

 

 

Enquiries:

 

Name:

Simon Pereira

Company Secretary

Address:

Computacenter plc

Hatfield Avenue

Hatfield

Hertfordshire

AL10 9TW

Telephone:

+44 (0) 7385 514 715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANDPALKSEEA
Date   Source Headline
1st Aug 20246:03 pmRNSTransaction in Own Shares
1st Aug 202412:00 pmRNSTotal Voting Rights
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
31st Jul 20246:21 pmRNSTransaction in Own Shares
30th Jul 20246:22 pmRNSTransaction in Own Shares
30th Jul 202410:15 amRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:10 amRNSShare Buyback Programme – 26 July 2024
26th Jul 20247:00 amRNSTrading Update and Return of Value – 26 July 2024
2nd Jul 202410:00 amRNSDirectorate Change -Confirmation of Effective Date
5th Jun 20247:00 amRNSCapital Markets Day
14th May 20242:00 pmRNSResult of AGM
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.